Gonavet Veyx 50 µg/ml solution for injection for cattle, pigs and horses
Gonavet Veyx 50 µg/ml solution for injection for cattle, pigs and horses
Authorised
- Gonadorelin (6-D-phenylalanine) acetate
Product identification
Medicine name:
Gonavet Veyx 50 µg/ml solution for injection for cattle, pigs and horses
GONAVET VEYX 50 ΜG/ML SOLUTION INJECTABLE POUR BOVINS PORCINS ET CHEVAUX
Active substance:
- Gonadorelin (6-D-phenylalanine) acetate
Target species:
-
Cattle
-
Pig
-
Horse
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Gonadorelin (6-D-phenylalanine) acetate52.40/microgram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Milk0hour
-
Meat and offal0day
-
-
Pig
-
Meat and offal0day
-
-
-
Intramuscular use
-
Cattle
-
Milk0hour
-
Meat and offal0day
-
-
Horse
-
Milk0day
-
Meat and offal0day
-
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH01CA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Package description:
- (ID3) 50 millilitre(s): unspecified outer container with 1 Vial (glass) with 50 millilitre(s)
- (ID2) 20 millilitre(s): unspecified outer container with 1 Vial (glass) with 20 millilitre(s)
- (ID1) 10 millilitre(s): unspecified outer container with 1 Vial (glass) with 10 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx Pharma GmbH
- Veyx-Pharma B.V.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/7967404 1/2015
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0158/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Estonia
-
France
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 14/02/2022
French (PDF)
Published on: 7/04/2022
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 15/10/2025
Combined File of all Documents
English (PDF)
Download Published on: 4/12/2025